Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G ROSENBLUM

Showing results (181-190 of 243) with videos related to

Pageof 25
Sort By:
Gynecologic Oncology Reports|April 19, 2021
Diaphragm hernia after debulking surgery in patients with ovarian cancerSarah Ehmann, Emeline M Aviki, Yukio Sonoda, et al.
Neoplasia (New York, N.Y.)|October 8, 2010
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activityHong Zhou, Yuying Liu, Lawrence H Cheung, et al.
The American Surgeon|July 1, 1994
Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields: a prospective four year experience with 34 patientsJ P Hoffman, R Lanciano, N Z Carp, et al.
Clinical Nuclear Medicine|May 1, 1989
Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factorK P O'Boyle, D Colletti, C Mazurek, et al.
Lancet (London, England)|May 11, 1991
Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemiaC F LeMaistre, M G Rosenblum, J M Reuben, et al.
The American Journal of Hospice & Palliative Care|February 14, 2026
Intimacy After Diagnosis: Navigating Sexual Health Conversations and Disparities Among Cancer SurvivorsTolulope Ilori, Katherine Gerber, Sara Burke, et al.
Journal of Contemporary Brachytherapy|October 23, 2014
Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancerHarriet Belding Eldredge-Hindy, Gary Eastwick, Pramila Rani Anne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 16, 2018
Light-enhanced VEGFAnette Weyergang, Ane S Fremstedal, Ellen Skarpen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGelAndrew R Hsu, Weibo Cai, Anand Veeravagu, et al.
Pageof 25

Showing results (181-190 of 243) with videos related to

Sort By:
Pageof 25
Gynecologic Oncology Reports|April 19, 2021
Diaphragm hernia after debulking surgery in patients with ovarian cancerSarah Ehmann, Emeline M Aviki, Yukio Sonoda, et al.
Neoplasia (New York, N.Y.)|October 8, 2010
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activityHong Zhou, Yuying Liu, Lawrence H Cheung, et al.
The American Surgeon|July 1, 1994
Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields: a prospective four year experience with 34 patientsJ P Hoffman, R Lanciano, N Z Carp, et al.
Clinical Nuclear Medicine|May 1, 1989
Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factorK P O'Boyle, D Colletti, C Mazurek, et al.
Lancet (London, England)|May 11, 1991
Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemiaC F LeMaistre, M G Rosenblum, J M Reuben, et al.
The American Journal of Hospice & Palliative Care|February 14, 2026
Intimacy After Diagnosis: Navigating Sexual Health Conversations and Disparities Among Cancer SurvivorsTolulope Ilori, Katherine Gerber, Sara Burke, et al.
Journal of Contemporary Brachytherapy|October 23, 2014
Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancerHarriet Belding Eldredge-Hindy, Gary Eastwick, Pramila Rani Anne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 16, 2018
Light-enhanced VEGFAnette Weyergang, Ane S Fremstedal, Ellen Skarpen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGelAndrew R Hsu, Weibo Cai, Anand Veeravagu, et al.
Pageof 25